Quick Facts
FONT-SIZE Plus   Neg
Share SHARE

Actuant Executives Adopt 10b5-1 Plans - Quick Facts

RELATED NEWS
Trade ATU now with 

Actuant Corp. (ATU: Quote) announced that certain of its executives have adopted prearranged trading plans in accordance with guidelines specified by Rule 10b5-1 under the Securities Exchange Act of 1934 and the Company's policies with respect to insider sales.

As per the 10b5-1 plans, the executives (Arzbaecher, Goldstein, Kobylinski, Lampereur) will be exercising stock options and immediately selling the shares of Actuant stock because the underlying options are approaching the end of their 10 year term. In addition, Arzbaecher and Boel plan to sell certain shares held outright. The transactions may take place from time-to-time on or after April 5, 2012, subject to certain 10b5-1 plan criteria, including certain minimum price levels and daily volume activity.

Click here to receive FREE breaking news email alerts for Actuant Corp. and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
Suggesting that the economy is gaining traction, the Conference Board released a report on Thursday showing a bigger than expected increase by its index of leading U.S. economic indicators in July. Results of a survey released by the Federal Reserve Bank of Philadelphia on Thursday showed that regional manufacturing activity unexpectedly grew at an accelerated rate in the month of August, with the index of activity in the sector reaching a three-year high. Existing home sales in U.S. unexpectedly rose to a ten-month high in the month of July, according to a report released by the National Association of Realtors on Thursday. NAR said existing home sales climbed to a seasonally adjusted annual rate of 5.15 million in July from a downwardly revised 5.03 million in June.
comments powered by Disqus
FREE Newsletters, Analysis & Alerts

 

Stay informed with our FREE daily Newsletters and real-time breaking News Alerts. Sign up to receive the latest information on business news, health, technology, biotech, market analysis, currency trading and more.